Rezolute
Price & Volume
Stats
See more52W Range | $0.72-$6.09 |
Market Cap | $285M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.14 |
News
See moreYahoo Finance • 10 months ago
Rezolute to Participate in BTIG’s 3rd Annual Ophthalmology Day
Yahoo Finance • 10 months ago
Rezolute Reports First Quarter Fiscal 2024 Results
Yahoo Finance • 11 months ago
Rezolute Receives Priority Medicines (PRIME) Eligibility from European Medicines Agency for Enhanced Regulatory Support of RZ358 in Congenital Hyperinsulinism
Yahoo Finance • 11 months ago
Rezolute Announces Further Evidence of RZ358’s Efficacy in Tumor-Mediated Hyperinsulinism
About
CEO | Mr. Nevan Charles Elam J.D. |
Address | 201 Redwood Shores Parkway, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 41 |
